| KROS Average Annual Return Chart Since 2020 | |||
Also see: • KROS stock yearly return 2021 • KROS stock yearly return 2022 • KROS stock yearly return 2023 • KROS YTD return | |||
| Average Annual Return Benchmarks |
|
Compare KROS average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| KROS Share Performance |
| KROS Average Annual Return Table Since 2020 | ||||||||||||||||||||||||||||||
KROS average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Keros Therapeutics Inc |
| Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, and in patients with myelofibrosis. Its second product candidate, KER-012, is being developed for the treatment of pulmonary arterial hypertension, or PAH, and for the treatment of cardiovascular disorders. The KROS average annual return since 2020 is shown above.
The Average Annual Return on the KROS average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether KROS average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the KROS average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| KROS Current Stock Quote |
 Free KROS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Keros Therapeutics (KROS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
KRRO Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!